艾尔免疫 ALT
$2.08 +$0.11 (+5.58%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $2.07 -0.48%
开盘$1.97
昨收$1.97
当日区间$1.95 – $2.10
成交量2.77M
市值$404.60M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00-100.0% YoY
营业利润-$26.23M-14.4% YoY
净利润-$22.83M-3.1% YoY
摊薄每股收益-$0.12+55.6% YoY
自由现金流-$24.25M-25.3% YoY
经营现金流-$24.22M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-323,306.5%
净利率-296,000.0%
净资产收益率-28.9%
资产收益率-25.6%
投入资本回报率-29.2%
流动比率26.78
负债/资产比率10.1%
现金及投资$326.28M
总负债$35.75M
净现金（净负债）$290.54M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $0.00 | $0.00 | $41,000.00 | $26,000.00 | $5,000.00 |
| 营业总收入 | $0.00 | $0.00 | $41,000.00 | $26,000.00 | $5,000.00 |
| 营业费用 | $26.23M | $24.24M | $94.53M | $28.92M | $20.86M |
| 销售及管理费用 | $7.57M | $8.05M | $28.10M | $10.51M | $5.90M |
| -管理费用 | $7.57M | $8.05M | $28.10M | $10.51M | $5.90M |
| 研发费用 | $18.66M | $16.19M | $66.43M | $18.41M | $14.96M |
| 营业利润 | -$26.23M | -$24.24M | -$94.49M | -$28.89M | -$20.86M |
| 非经营性利息净收入（支出） | $3.43M | $1.83M | $5.91M | $1.56M | $1.93M |
| 非经营性利息收入 | $4.53M | $2.90M | $7.54M | $2.44M | $2.43M |
| 非经营性利息支出 | $1.10M | $1.07M | $1.64M | $876,000.00 | $495,000.00 |
| 其他收入（支出） | -$25,000.00 | -$152,000.00 | -$190,000.00 | -$27,000.00 | -$86,000.00 |
| 其他非经营性收入（支出） | -$25,000.00 | -$152,000.00 | -$190,000.00 | -$27,000.00 | -$86,000.00 |
| 税前利润 | -$22.83M | -$22.56M | -$88.77M | -$27.36M | -$19.01M |
| 税费 | $0.00 | $0.00 | -$681,000.00 | $0.00 | $0.00 |
| 净利润 | -$22.83M | -$22.56M | -$88.09M | -$27.36M | -$19.01M |
| 持续经营利润 | -$22.83M | -$22.56M | -$88.09M | -$27.36M | -$19.01M |
| 归属母公司净利润 | -$22.83M | -$22.56M | -$88.09M | -$27.36M | -$19.01M |
| 归属普通股股东净利润 | -$22.83M | -$22.56M | -$88.09M | -$27.36M | -$19.01M |
| 基本每股收益 | -$0.12 | -$0.18 | -$1.00 | -$0.27 | -$0.21 |
| 摊薄每股收益 | -$0.12 | -$0.18 | -$1.00 | -$0.27 | -$0.21 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $527.21M | $335.63M | $279.93M | $279.93M | $218.45M |
| 流动资产合计 | $334.82M | $334.68M | $278.19M | $278.19M | $216.62M |
| 现金及现金等价物与短期投资 | $326.28M | $331.54M | $273.46M | $273.46M | $210.78M |
| -现金及现金等价物 | $63.01M | $97.60M | $43.76M | $43.76M | $61.24M |
| -短期投资 | $263.27M | $233.94M | $229.70M | $229.70M | $149.54M |
| 应收款 | $3.34M | $1.67M | $1.74M | $1.74M | $1.39M |
| -应收账款 | $3.34M | $1.67M | $1.22M | $1.22M | $845,000.00 |
| -应收税款 | $0.00 | $0.00 | $518,000.00 | $518,000.00 | $547,000.00 |
| 受限现金 | $42,000.00 | $42,000.00 | $42,000.00 | $42,000.00 | $42,000.00 |
| 其他流动资产 | $5.15M | $1.43M | $2.96M | $2.96M | $4.41M |
| 非流动资产合计 | $192.40M | $954,000.00 | $1.74M | $1.74M | $1.83M |
| 固定资产净值 | $60,000.00 | $208,000.00 | $312,000.00 | $312,000.00 | $337,000.00 |
| -固定资产原值 | $60,000.00 | $208,000.00 | $2.64M | $2.64M | $337,000.00 |
| 投资及预付款 | $192.25M | – | – | – | – |
| 其他非流动资产 | $90,000.00 | $746,000.00 | $1.43M | $1.43M | $1.50M |
| 负债合计 | $53.00M | $51.64M | $55.04M | $55.04M | $32.85M |
| 流动负债合计 | $12.50M | $11.32M | $15.00M | $15.00M | $12.61M |
| 应付款 | $1.27M | $1.53M | $2.72M | $2.72M | $4.80M |
| -应付账款 | $1.27M | $1.53M | $2.72M | $2.72M | $4.80M |
| 一年内应计费用 | $10.96M | $9.53M | $12.02M | $12.02M | $7.56M |
| 短期债务及融资租赁负债 | $274,000.00 | $265,000.00 | $256,000.00 | $256,000.00 | $247,000.00 |
| -一年内到期融资租赁负债 | $274,000.00 | $265,000.00 | $256,000.00 | $256,000.00 | $247,000.00 |
| 非流动负债合计 | $40.50M | $40.32M | $40.04M | $40.04M | $20.24M |
| 长期债务及融资租赁负债 | $35.75M | $35.58M | $35.43M | $35.43M | $15.66M |
| -长期债务 | $34.74M | $34.51M | $34.29M | $34.29M | $14.45M |
| -长期融资租赁负债 | $1.00M | $1.08M | $1.15M | $1.15M | $1.21M |
| 一年以上递延负债 | $147,000.00 | $147,000.00 | $160,000.00 | $160,000.00 | – |
| 其他非流动负债 | $4.61M | $4.59M | $4.45M | $4.45M | $4.58M |
| 股东权益合计 | $474.21M | $283.99M | $224.89M | $224.89M | $185.60M |
| 股东权益 | $474.21M | $283.99M | $224.89M | $224.89M | $185.60M |
| 股本 | $19,000.00 | $13,000.00 | $11,000.00 | $11,000.00 | $10,000.00 |
| -普通股 | $19,000.00 | $13,000.00 | $11,000.00 | $11,000.00 | $10,000.00 |
| 资本公积 | $1.18B | $961.24M | $879.29M | $879.29M | $812.73M |
| 留存收益 | -$694.87M | -$672.05M | -$649.48M | -$649.48M | -$622.13M |
| 不影响留存收益的损益 | -$6.04M | -$5.22M | -$4.93M | -$4.93M | -$5.02M |
| -累计折旧 | – | – | -$2.33M | -$2.33M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$24.22M | -$20.94M | -$67.54M | -$19.45M | -$11.90M |
| 持续经营经营活动现金流净额 | -$24.22M | -$20.94M | -$67.54M | -$19.45M | -$11.90M |
| 持续经营净利润 | -$22.83M | -$22.56M | -$88.09M | -$27.36M | -$19.01M |
| 持续经营损益 | $22,000.00 | $154,000.00 | $160,000.00 | $44,000.00 | $86,000.00 |
| 折旧、折耗与摊销 | $23,000.00 | $23,000.00 | $112,000.00 | $26,000.00 | $27,000.00 |
| 递延税款 | $0.00 | $0.00 | -$681,000.00 | $0.00 | $0.00 |
| 其他非现金项目 | $237,000.00 | $218,000.00 | $363,000.00 | $192,000.00 | $113,000.00 |
| 营运资金变动 | -$4.27M | -$1.99M | $6.75M | $3.62M | $3.53M |
| -应收款变动 | -$1.68M | $72,000.00 | $2.06M | -$345,000.00 | -$514,000.00 |
| -预付资产变动 | -$3.72M | $1.62M | -$204,000.00 | $1.70M | -$8,000.00 |
| -应付账款及应计费用变动 | $1.13M | -$3.68M | $4.90M | $2.26M | $4.06M |
| 投资活动现金流净额 | -$221.44M | -$3.69M | -$132.47M | -$79.16M | -$149.32M |
| 持续经营投资活动现金流净额 | -$221.44M | -$3.69M | -$132.47M | -$79.16M | -$149.32M |
| 固定资产购置及出售净额 | -$32,000.00 | -$21,000.00 | -$11,000.00 | -$1,000.00 | $0.00 |
| 投资购置及出售净额 | -$221.41M | -$3.67M | -$132.46M | -$79.16M | -$149.32M |
| 筹资活动现金流 | $211.07M | $78.47M | $206.84M | $81.13M | $39.35M |
| 持续经营筹资活动现金流净额 | $211.07M | $78.47M | $206.84M | $81.13M | $39.35M |
| 普通股发行净额 | $210.80M | $79.26M | $173.73M | $61.35M | $40.11M |
| 其他筹资费用净额 | $275,000.00 | -$784,000.00 | -$2.22M | -$515,000.00 | -$1.20M |
| 期末现金余额 | $63.05M | $97.64M | $43.80M | $43.80M | $61.28M |
| 现金净变动 | -$34.59M | $53.84M | $6.83M | -$17.48M | -$121.87M |
| 期初现金余额 | $97.64M | $43.80M | $36.97M | $61.28M | $183.15M |
| 自由现金流 | -$24.25M | -$20.96M | -$67.55M | -$19.45M | -$11.90M |
| 股票期权行使所得 | – | $0.00 | $332,000.00 | $291,000.00 | – |
| 债务发行及偿还净额 | – | – | $35.00M | $20.00M | $404,000.00 |
暂无评论——快来第一个聊聊 ALT。